These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nevada
|
27-2767540
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification Number)
|
|
|
|
|
100 Summit Lake Drive, Suite 100
Valhalla, New York
|
10595
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
|
|
|
|
Page
|
|
PART I. FINANCIAL INFORMATION
|
|
|
|
|
|
|
|
Item 1.
|
Financial Statements (unaudited)
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
Item 2.
|
||
|
|
|
|
|
Item 3.
|
||
|
|
|
|
|
Item 4.
|
||
|
|
|
|
|
PART II. OTHER INFORMATION
|
||
|
|
|
|
|
Item 1.
|
||
|
|
|
|
|
Item 1A.
|
||
|
|
|
|
|
Item 6.
|
||
|
|
|
|
|
SIGNATURES
|
||
|
|
September 30, 2014
|
|
December 31, 2013
|
||||
|
ASSETS
|
(in thousands, except par value and share amounts)
|
||||||
|
Current Assets:
|
|
|
|
|
|
||
|
Cash and cash equivalents
|
$
|
4,416
|
|
|
$
|
6,509
|
|
|
Accounts receivable, net
|
26,712
|
|
|
48,542
|
|
||
|
Inventories, net
|
46,557
|
|
|
49,643
|
|
||
|
Deferred income taxes
|
13,918
|
|
|
2,214
|
|
||
|
Prepaid income taxes
|
1,329
|
|
|
2,925
|
|
||
|
Prepaid expenses and other current assets
|
5,866
|
|
|
3,561
|
|
||
|
Total Current Assets
|
98,798
|
|
|
113,394
|
|
||
|
Property and equipment, net
|
5,174
|
|
|
7,369
|
|
||
|
Goodwill
|
80,974
|
|
|
—
|
|
||
|
Intangible assets, net
|
40,025
|
|
|
3,972
|
|
||
|
Deferred income taxes
|
6,101
|
|
|
827
|
|
||
|
Other assets
|
650
|
|
|
1,745
|
|
||
|
Total Assets
|
$
|
231,722
|
|
|
$
|
127,307
|
|
|
LIABILITIES, CONVERTIBLE PREFERRED STOCK AND
STOCKHOLDERS' EQUITY (DEFICIT)
|
|
|
|
|
|||
|
Current Liabilities:
|
|
|
|
|
|||
|
Revolving credit facilities
|
$
|
28,663
|
|
|
$
|
39,736
|
|
|
Term loan
|
—
|
|
|
14,500
|
|
||
|
Subordinated notes - related parties
|
7,506
|
|
|
—
|
|
||
|
Accounts payable
|
28,650
|
|
|
44,136
|
|
||
|
Due to shareholders
|
—
|
|
|
3,125
|
|
||
|
Other current liabilities
|
8,039
|
|
|
9,712
|
|
||
|
Total Current Liabilities
|
72,858
|
|
|
111,209
|
|
||
|
Series B redeemable preferred stock
|
14,621
|
|
|
13,713
|
|
||
|
Deferred income taxes
|
14,325
|
|
|
850
|
|
||
|
Subordinated notes
|
—
|
|
|
10,342
|
|
||
|
Other liabilities
|
2,041
|
|
|
1,986
|
|
||
|
Total Liabilities
|
103,845
|
|
|
138,100
|
|
||
|
Commitments and Contingencies
|
|
|
|
||||
|
Series A convertible preferred stock, $0.01 par value - 50,000,000 shares authorized;
48,689,555 shares issued and outstanding as of December 31, 2013
|
—
|
|
|
24,345
|
|
||
|
Stockholders' Equity (Deficit)
|
|
|
|
|
|
||
|
Common stock, $0.001 par value - 50,000,000 shares authorize
d; 42,011,463 a
nd 12,700,460 shares issued and outstanding as of September 30, 2014 and December 31, 2013, respectively
|
42
|
|
|
13
|
|
||
|
Additional paid-in capital
|
126,739
|
|
|
(54,031
|
)
|
||
|
Retained earnings
|
929
|
|
|
18,775
|
|
||
|
Accumulated other comprehensive income
|
167
|
|
|
105
|
|
||
|
Total Stockholders' Equity (Deficit)
|
127,877
|
|
|
(35,138
|
)
|
||
|
Total Liabilities, Convertible Preferred Stock and Stockholders' Equity (Deficit)
|
$
|
231,722
|
|
|
$
|
127,307
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
September 30, 2014
|
|
September 30, 2013
|
|
September 30, 2014
|
|
September 30, 2013
|
||||||||
|
|
(in thousands, except per-share data)
|
||||||||||||||
|
Net Revenue
|
$
|
33,325
|
|
|
$
|
38,299
|
|
|
$
|
93,909
|
|
|
$
|
92,352
|
|
|
Cost of Revenue
|
25,576
|
|
|
29,653
|
|
|
69,053
|
|
|
68,759
|
|
||||
|
Gross Profit
|
7,749
|
|
|
8,646
|
|
|
24,856
|
|
|
23,593
|
|
||||
|
Operating expenses:
|
|
|
|
|
|
|
|
||||||||
|
Selling and marketing
|
7,962
|
|
|
7,665
|
|
|
22,660
|
|
|
21,783
|
|
||||
|
Research and development
|
2,797
|
|
|
1,027
|
|
|
6,866
|
|
|
3,239
|
|
||||
|
General and administrative
|
4,311
|
|
|
1,648
|
|
|
12,582
|
|
|
5,678
|
|
||||
|
Business transaction costs
|
—
|
|
|
1,607
|
|
|
3,744
|
|
|
2,287
|
|
||||
|
Total operating expenses
|
15,070
|
|
|
11,947
|
|
|
45,852
|
|
|
32,987
|
|
||||
|
Operating loss
|
(7,321
|
)
|
|
(3,301
|
)
|
|
(20,996
|
)
|
|
(9,394
|
)
|
||||
|
Interest expense
|
866
|
|
|
2,017
|
|
|
6,161
|
|
|
4,580
|
|
||||
|
Other non-operating expense (income), net
|
334
|
|
|
(217
|
)
|
|
239
|
|
|
256
|
|
||||
|
Loss before income tax benefit
|
(8,521
|
)
|
|
(5,101
|
)
|
|
(27,396
|
)
|
|
(14,230
|
)
|
||||
|
Income tax benefit
|
(2,883
|
)
|
|
(3,699
|
)
|
|
(9,550
|
)
|
|
(7,186
|
)
|
||||
|
Net loss
|
$
|
(5,638
|
)
|
|
$
|
(1,402
|
)
|
|
$
|
(17,846
|
)
|
|
$
|
(7,044
|
)
|
|
|
|
|
|
|
|
|
|
||||||||
|
Net loss per share:
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
$
|
(0.13
|
)
|
|
$
|
(0.11
|
)
|
|
$
|
(0.46
|
)
|
|
$
|
(0.55
|
)
|
|
Diluted
|
$
|
(0.13
|
)
|
|
$
|
(0.11
|
)
|
|
$
|
(0.46
|
)
|
|
$
|
(0.55
|
)
|
|
Weighted average number of shares:
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
41,962
|
|
|
12,700
|
|
|
38,869
|
|
|
12,700
|
|
||||
|
Diluted
|
41,962
|
|
|
12,700
|
|
|
38,869
|
|
|
12,700
|
|
||||
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
September 30, 2014
|
|
September 30, 2013
|
|
September 30, 2014
|
|
September 30, 2013
|
||||||||
|
|
(in thousands)
|
||||||||||||||
|
Net loss
|
$
|
(5,638
|
)
|
|
$
|
(1,402
|
)
|
|
$
|
(17,846
|
)
|
|
$
|
(7,044
|
)
|
|
|
|
|
|
|
|
|
|
||||||||
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
||||||||
|
Foreign currency translation adjustment
|
(574
|
)
|
|
138
|
|
|
62
|
|
|
29
|
|
||||
|
Other comprehensive income (loss)
|
(574
|
)
|
|
138
|
|
|
62
|
|
|
29
|
|
||||
|
Comprehensive loss
|
$
|
(6,212
|
)
|
|
$
|
(1,264
|
)
|
|
$
|
(17,784
|
)
|
|
$
|
(7,015
|
)
|
|
|
Nine Months Ended
|
||||||
|
|
September 30, 2014
|
|
September 30, 2013
|
||||
|
|
(in thousands)
|
||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES
|
|
|
|
|
|
||
|
Net loss
|
$
|
(17,846
|
)
|
|
$
|
(7,044
|
)
|
|
Adjustments to reconcile net loss to net cash provided by (used for) operating activities:
|
|
|
|
||||
|
Depreciation and amortization
|
4,339
|
|
|
3,051
|
|
||
|
Amortization of intangible assets
|
808
|
|
|
712
|
|
||
|
Amortization of debt financing costs
|
2,587
|
|
|
1,209
|
|
||
|
Stock-based compensation
|
3,916
|
|
|
1,919
|
|
||
|
Accrued interest on Series B redeemable preferred stock
|
908
|
|
|
745
|
|
||
|
Paid in kind interest
|
953
|
|
|
—
|
|
||
|
Deferred income taxes
|
(10,282
|
)
|
|
(5,224
|
)
|
||
|
Reversal of sales returns reserve
|
(3,534
|
)
|
|
(5,756
|
)
|
||
|
Reversal of doubtful accounts
|
(8
|
)
|
|
(350
|
)
|
||
|
Provision for obsolete inventory
|
179
|
|
|
(347
|
)
|
||
|
Loss (Gain) on disposal of property and equipment
|
9
|
|
|
(9
|
)
|
||
|
Changes in operating assets and liabilities:
|
|
|
|
||||
|
Accounts receivable
|
25,419
|
|
|
38,882
|
|
||
|
Inventories
|
3,559
|
|
|
(21,217
|
)
|
||
|
Accounts payable
|
(16,027
|
)
|
|
26,290
|
|
||
|
Due to shareholders
|
(3,125
|
)
|
|
(3,125
|
)
|
||
|
Prepaid expenses and other assets
|
(2,418
|
)
|
|
(3,832
|
)
|
||
|
Income taxes payable
|
1,784
|
|
|
(8,105
|
)
|
||
|
Other liabilities
|
(3,318
|
)
|
|
(2,540
|
)
|
||
|
Net cash provided by (used for) operating activities
|
(12,097
|
)
|
|
15,259
|
|
||
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
|
|
|
||||
|
Purchase of property and equipment
|
(1,947
|
)
|
|
(4,109
|
)
|
||
|
Cash acquired in business combination
|
4,093
|
|
|
—
|
|
||
|
Net cash provided by (used for) investing activities
|
2,146
|
|
|
(4,109
|
)
|
||
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
|
|
|
||||
|
Borrowings on revolving credit facilities
|
93,057
|
|
|
30,250
|
|
||
|
Repayment of revolving credit facilities
|
(104,130
|
)
|
|
(33,064
|
)
|
||
|
Repayment of capital leases
|
(25
|
)
|
|
—
|
|
||
|
Repayment of term loan
|
(14,500
|
)
|
|
(17,500
|
)
|
||
|
Repayment of subordinated notes
|
(10,789
|
)
|
|
—
|
|
||
|
Proceeds from sale of common stock, net of issuance costs
|
37,230
|
|
|
—
|
|
||
|
Proceeds from exercise of stock options
|
1,552
|
|
|
—
|
|
||
|
Debt financing costs
|
(1,509
|
)
|
|
(1,021
|
)
|
||
|
Proceeds from issuance of subordinated notes
|
7,000
|
|
|
10,000
|
|
||
|
Net cash provided by (used for) financing activities
|
7,886
|
|
|
(11,335
|
)
|
||
|
Effect of exchange rate changes on cash and cash equivalents
|
(28
|
)
|
|
28
|
|
||
|
Net decrease in cash and cash equivalents
|
(2,093
|
)
|
|
(157
|
)
|
||
|
Cash and cash equivalents - beginning of period
|
6,509
|
|
|
5,219
|
|
||
|
Cash and cash equivalents - end of period
|
$
|
4,416
|
|
|
$
|
5,062
|
|
|
|
|
|
|
||||
|
SUPPLEMENTAL DISCLOSURE OF INFORMATION
|
|
|
|
||||
|
Cash paid for interest
|
$
|
1,782
|
|
|
$
|
2,349
|
|
|
Cash paid for income taxes
|
$
|
190
|
|
|
$
|
8,224
|
|
|
Value of shares issued to acquire HyperSound business
|
$
|
113,782
|
|
|
$
|
—
|
|
|
|
Series A Convertible Preferred Stock
|
|
Common Stock
|
|
Additional Paid-In Capital
|
|
Retained Earnings
|
|
Accumulated Other Comprehensive Income
|
|
Total
|
||||||||||||||||
|
|
Shares
|
Amount
|
|
Shares
|
Amount
|
|
|
|
|
||||||||||||||||||
|
|
(in thousands)
|
||||||||||||||||||||||||||
|
Balance at December 31, 2013
|
48,690
|
|
$
|
24,345
|
|
|
12,700
|
|
$
|
13
|
|
|
$
|
(54,031
|
)
|
|
$
|
18,775
|
|
|
$
|
105
|
|
|
$
|
(35,138
|
)
|
|
Net loss
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
(17,846
|
)
|
|
—
|
|
|
(17,846
|
)
|
||||||
|
Other comprehensive income
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
62
|
|
|
62
|
|
||||||
|
Adjustment for reverse merger
|
|
|
|
7,275
|
|
7
|
|
|
113,775
|
|
|
|
|
—
|
|
|
113,782
|
|
|||||||||
|
Conversion of Series A Preferred
|
(48,690
|
)
|
(24,345
|
)
|
|
17,527
|
|
18
|
|
|
24,327
|
|
|
|
|
—
|
|
|
24,345
|
|
|||||||
|
Cashless exercise of warrants
|
—
|
|
—
|
|
|
24
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Sale of common stock, net of issuance costs
|
—
|
|
—
|
|
|
4,000
|
|
4
|
|
|
37,226
|
|
|
—
|
|
|
—
|
|
|
37,230
|
|
||||||
|
Stock options exercised and related tax activity
|
—
|
|
—
|
|
|
486
|
|
—
|
|
|
1,526
|
|
|
—
|
|
|
—
|
|
|
1,526
|
|
||||||
|
Stock-based compensation
|
—
|
|
—
|
|
|
—
|
|
—
|
|
|
3,916
|
|
|
|
|
—
|
|
|
3,916
|
|
|||||||
|
Balance at September 30, 2014
|
—
|
|
$
|
—
|
|
|
42,012
|
|
$
|
42
|
|
|
$
|
126,739
|
|
|
$
|
929
|
|
|
$
|
167
|
|
|
$
|
127,877
|
|
|
|
Nine Months Ended
|
||||||
|
|
September 30,
|
||||||
|
|
2014
|
|
2013
|
||||
|
|
(in thousands)
|
||||||
|
Legal fees
|
$
|
786
|
|
|
$
|
1,179
|
|
|
Accounting fees
|
84
|
|
|
968
|
|
||
|
Advisory fees
|
2,219
|
|
|
—
|
|
||
|
Termination and severance
|
450
|
|
|
—
|
|
||
|
Other
|
205
|
|
|
140
|
|
||
|
Total Transaction Costs
|
$
|
3,744
|
|
|
$
|
2,287
|
|
|
|
(in thousands)
|
||
|
Fair Value of Parametric shares outstanding
|
$
|
104,027
|
|
|
Fair Value of Parametric stock options
|
9,755
|
|
|
|
Purchase Price
|
$
|
113,782
|
|
|
|
(in thousands)
|
||
|
Cash and cash equivalents
|
$
|
4,093
|
|
|
Accounts receivable
|
47
|
|
|
|
Deferred tax asset
|
6,696
|
|
|
|
Other current assets
|
710
|
|
|
|
Property and equipment
|
206
|
|
|
|
Intangible assets:
|
|
||
|
In-process research and development (IPR&D)
|
27,100
|
|
|
|
Developed technology
|
8,880
|
|
|
|
Customer relationships
|
270
|
|
|
|
Trade name
|
170
|
|
|
|
Goodwill
|
80,974
|
|
|
|
Accounts payable and accrued liabilities
|
(1,769
|
)
|
|
|
Capital lease obligation
|
(120
|
)
|
|
|
Deferred tax liabilities
|
(13,475
|
)
|
|
|
Total Net Assets Acquired
|
$
|
113,782
|
|
|
|
Three Months Ended
|
||||||
|
|
September 30, 2013
|
||||||
|
|
Reported
|
|
Proforma
|
||||
|
|
(in thousands)
|
||||||
|
Net Revenue
|
$
|
38,299
|
|
|
$
|
38,386
|
|
|
Net Loss
|
$
|
(1,402
|
)
|
|
$
|
(4,023
|
)
|
|
|
Nine Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
September 30, 2014
|
|
September 30, 2013
|
||||||||||||
|
|
Reported
|
|
Proforma
|
|
Reported
|
|
Proforma
|
||||||||
|
|
(in thousands)
|
||||||||||||||
|
Net Revenue
|
$
|
93,909
|
|
|
$
|
93,909
|
|
|
$
|
92,352
|
|
|
$
|
92,806
|
|
|
Net Loss
|
$
|
(17,846
|
)
|
|
$
|
(19,936
|
)
|
|
$
|
(7,044
|
)
|
|
$
|
(13,612
|
)
|
|
•
|
Level 1 — Quoted prices in active markets for identical assets or liabilities.
|
|
•
|
Level 2 — Observable inputs other than quoted prices included in Level 1, such as quoted prices for markets that are not active, or other inputs that are observable or can be corroborated by observable market data.
|
|
•
|
Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.
|
|
|
December 31, 2013
|
||||||||||||||
|
|
Level I
|
|
Level II
|
|
Level III
|
|
Total
|
||||||||
|
|
(in thousands)
|
||||||||||||||
|
Financial Assets and Liabilities:
|
|
|
|
|
|
|
|
||||||||
|
Cash and cash equivalents - money market funds
|
$
|
19
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
19
|
|
|
Total financial assets
|
$
|
19
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
19
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Other current liabilities - derivative liabilities
|
$
|
—
|
|
|
$
|
(392
|
)
|
|
$
|
—
|
|
|
$
|
(392
|
)
|
|
Total financial liabilities
|
$
|
—
|
|
|
$
|
(392
|
)
|
|
$
|
—
|
|
|
$
|
(392
|
)
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
September 30,
|
|
September 30,
|
||||||||||||
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
|
|
(in thousands)
|
||||||||||||||
|
Balance, beginning of period
|
$
|
2,429
|
|
|
$
|
1,636
|
|
|
$
|
6,266
|
|
|
$
|
7,748
|
|
|
Reserve accrual
|
2,686
|
|
|
3,599
|
|
|
7,526
|
|
|
9,554
|
|
||||
|
Recoveries and deductions, net
|
(2,383
|
)
|
|
(3,243
|
)
|
|
(11,060
|
)
|
|
(15,310
|
)
|
||||
|
Balance, end of period
|
$
|
2,732
|
|
|
$
|
1,992
|
|
|
$
|
2,732
|
|
|
$
|
1,992
|
|
|
|
September 30, 2014
|
|
December 31, 2013
|
||||
|
|
(in thousands)
|
||||||
|
Raw materials
|
$
|
3,129
|
|
|
$
|
5,499
|
|
|
Finished goods
|
43,428
|
|
|
44,144
|
|
||
|
Total inventories, net
|
$
|
46,557
|
|
|
$
|
49,643
|
|
|
|
September 30, 2014
|
|
December 31, 2013
|
||||
|
|
(in thousands)
|
||||||
|
Machinery and equipment
|
$
|
510
|
|
|
$
|
249
|
|
|
Software and software development
|
748
|
|
|
581
|
|
||
|
Furniture and fixtures
|
222
|
|
|
144
|
|
||
|
Tooling
|
2,047
|
|
|
1,756
|
|
||
|
Leasehold improvements
|
103
|
|
|
59
|
|
||
|
Demonstration units and convention booths
|
11,256
|
|
|
10,014
|
|
||
|
Total property and equipment, gross
|
14,886
|
|
|
12,803
|
|
||
|
Less: accumulated depreciation and amortization
|
(9,712
|
)
|
|
(5,434
|
)
|
||
|
Total property and equipment, net
|
$
|
5,174
|
|
|
$
|
7,369
|
|
|
|
(in thousands)
|
||
|
Balance as of January 1, 2014
|
$
|
—
|
|
|
Activity in 2014
|
|
||
|
Acquisition of HyperSound business
|
$
|
80,974
|
|
|
Balance as of September 30, 2014
|
$
|
80,974
|
|
|
|
September 30, 2014
|
||||||||||
|
|
Gross Carrying Value
|
|
Accumulated Amortization
|
|
Net Book Value
|
||||||
|
|
(in thousands)
|
||||||||||
|
Customer relationships
|
$
|
5,840
|
|
|
$
|
2,211
|
|
|
$
|
3,629
|
|
|
Non-compete agreements
|
179
|
|
|
134
|
|
|
45
|
|
|||
|
In-process Research and Development
|
27,100
|
|
|
—
|
|
|
27,100
|
|
|||
|
Developed technology
|
8,880
|
|
|
80
|
|
|
8,800
|
|
|||
|
Trade names
|
170
|
|
|
25
|
|
|
145
|
|
|||
|
Patent and trademarks
|
306
|
|
|
—
|
|
|
306
|
|
|||
|
Total Intangible Assets
|
$
|
42,475
|
|
|
$
|
2,450
|
|
|
$
|
40,025
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
||||||
|
|
December 31, 2013
|
||||||||||
|
|
Gross Carrying Value
|
|
Accumulated Amortization
|
|
Net Book Value
|
||||||
|
|
(in thousands)
|
||||||||||
|
Customer relationships
|
$
|
5,526
|
|
|
$
|
1,623
|
|
|
$
|
3,903
|
|
|
Non-compete agreements
|
177
|
|
|
108
|
|
|
69
|
|
|||
|
Total
|
$
|
5,703
|
|
|
$
|
1,731
|
|
|
$
|
3,972
|
|
|
|
(in thousands)
|
||
|
2014
|
$
|
572
|
|
|
2015
|
2,348
|
|
|
|
2016
|
2,053
|
|
|
|
2017
|
1,885
|
|
|
|
2018
|
1,805
|
|
|
|
Thereafter
|
3,956
|
|
|
|
Total
|
$
|
12,619
|
|
|
|
September 30, 2014
|
|
December 31, 2013
|
||||
|
|
(in thousands)
|
||||||
|
Revolving credit facility, maturing March 2019
|
$
|
28,663
|
|
|
$
|
—
|
|
|
Revolving line of credit, repaid in March 2014
|
—
|
|
|
39,736
|
|
||
|
Term loans
|
—
|
|
|
14,500
|
|
||
|
Subordinated notes
|
7,506
|
|
|
10,342
|
|
||
|
Total outstanding debt
|
36,169
|
|
|
64,578
|
|
||
|
Less: current portion of revolving line of credit
|
(28,663
|
)
|
|
(39,736
|
)
|
||
|
Less: current portion of term loan
|
—
|
|
|
(14,500
|
)
|
||
|
Less: current portion of subordinated notes
|
(7,506
|
)
|
|
—
|
|
||
|
Total noncurrent portion of long-term debt
|
$
|
—
|
|
|
$
|
10,342
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
September 30,
|
|
September 30,
|
||||||||||||
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
|
|
(in thousands)
|
||||||||||||||
|
Income tax benefit
|
$
|
(2,883
|
)
|
|
$
|
(3,699
|
)
|
|
$
|
(9,550
|
)
|
|
$
|
(7,186
|
)
|
|
Effective income tax rate
|
33.8
|
%
|
|
72.5
|
%
|
|
34.9
|
%
|
|
50.5
|
%
|
||||
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
September 30,
|
|
September 30,
|
||||||||||||
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
|
|
(in thousands)
|
||||||||||||||
|
Cost of revenue
|
$
|
151
|
|
|
$
|
15
|
|
|
$
|
219
|
|
|
$
|
56
|
|
|
Selling and marketing
|
279
|
|
|
93
|
|
|
607
|
|
|
251
|
|
||||
|
Product development
|
241
|
|
|
93
|
|
|
656
|
|
|
249
|
|
||||
|
General and administrative
|
848
|
|
|
455
|
|
|
2,434
|
|
|
1,363
|
|
||||
|
Total stock-based compensation
|
$
|
1,519
|
|
|
$
|
656
|
|
|
$
|
3,916
|
|
|
$
|
1,919
|
|
|
Related income tax benefit
|
$
|
608
|
|
|
$
|
262
|
|
|
$
|
1,567
|
|
|
$
|
767
|
|
|
|
$
|
911
|
|
|
$
|
394
|
|
|
$
|
2,349
|
|
|
$
|
1,152
|
|
|
|
(in thousands)
|
|
|
Balance at December 31, 2013
|
1,439
|
|
|
VTBH 2011 Plan terminated at Merger
|
(1,439
|
)
|
|
2013 Plan adopted at Merger
|
2,372
|
|
|
Options granted
|
(1,777
|
)
|
|
Restricted Stock granted
|
(6
|
)
|
|
Forfeited/Expired shares added back
|
50
|
|
|
Balance at September 30, 2014
|
639
|
|
|
|
Options Outstanding
|
||||||||
|
|
Number of Shares Underlying Outstanding Options
|
|
Weighted-Average Exercise Price
|
|
Weighted-Average Remaining Contractual Term
|
|
Aggregate Intrinsic Value
|
||
|
|
|
|
|
|
(In years)
|
|
|
||
|
Outstanding at December 31, 2013
|
3,960,793
|
|
|
4.71
|
|
8.45
|
|
3,031,094
|
|
|
Granted
|
1,777,327
|
|
|
11.92
|
|
|
|
|
|
|
Assumed in acquisition
|
1,392,854
|
|
|
6.02
|
|
|
|
|
|
|
Exercised
|
(485,559
|
)
|
|
3.19
|
|
|
|
|
|
|
Forfeited
|
(218,749
|
)
|
|
5.52
|
|
|
|
|
|
|
Outstanding at September 30, 2014
|
6,426,666
|
|
|
7.08
|
|
7.04
|
|
13,476,250
|
|
|
Vested and expected to vest at September 30, 2014
|
6,426,666
|
|
|
7.08
|
|
7.04
|
|
13,476,250
|
|
|
Exercisable at September 30, 2014
|
3,041,492
|
|
|
4.83
|
|
5.31
|
|
9,655,119
|
|
|
Expected term (in years)
|
6.0 - 6.3
|
|
Risk-free interest rate
|
1.8% - 2.0%
|
|
Expected volatility
|
47.5% - 49.8%
|
|
Dividend rate
|
0%
|
|
|
Shares
|
|
Weighted Average Grant Date Fair Value Per Share
|
|||
|
Nonvested restricted stock at December 31, 2013
|
—
|
|
|
$
|
—
|
|
|
Granted
|
6,396
|
|
|
15.63
|
|
|
|
Nonvested restricted stock at September 30, 2014
|
6,396
|
|
|
15.63
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
September 30,
|
|
September 30,
|
||||||||||||
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
|
|
(in thousands, except per-share data)
|
||||||||||||||
|
Net Loss
|
$
|
(5,638
|
)
|
|
$
|
(1,402
|
)
|
|
$
|
(17,846
|
)
|
|
$
|
(7,044
|
)
|
|
|
|
|
|
|
|
|
|
||||||||
|
Weighted average common shares outstanding — Basic
|
41,962
|
|
|
12,700
|
|
|
38,869
|
|
|
12,700
|
|
||||
|
Plus incremental shares from assumed conversions:
|
|
|
|
|
|
|
|
||||||||
|
Dilutive effect of stock options
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Weighted average common shares outstanding — Diluted
|
41,962
|
|
|
12,700
|
|
|
38,869
|
|
|
12,700
|
|
||||
|
Net loss per share:
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
$
|
(0.13
|
)
|
|
$
|
(0.11
|
)
|
|
$
|
(0.46
|
)
|
|
$
|
(0.55
|
)
|
|
Diluted
|
$
|
(0.13
|
)
|
|
$
|
(0.11
|
)
|
|
$
|
(0.46
|
)
|
|
$
|
(0.55
|
)
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||
|
|
September 30,
|
|
September 30,
|
||||||||
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||
|
|
(in thousands)
|
||||||||||
|
Stock options
|
6,118
|
|
|
3,658
|
|
|
6,066
|
|
|
3,658
|
|
|
Warrants
|
31
|
|
|
—
|
|
|
38
|
|
|
—
|
|
|
Unvested restricted stock awards
|
6
|
|
|
—
|
|
|
6
|
|
|
—
|
|
|
Total
|
6,155
|
|
|
3,658
|
|
|
6,110
|
|
|
3,658
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
September 30,
|
|
September 30,
|
||||||||||||
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
|
|
(in thousands)
|
||||||||||||||
|
United States
|
$
|
18,689
|
|
|
$
|
17,810
|
|
|
$
|
56,668
|
|
|
$
|
51,093
|
|
|
International
|
14,636
|
|
|
20,489
|
|
|
37,241
|
|
|
41,259
|
|
||||
|
Total revenues
|
$
|
33,325
|
|
|
$
|
38,299
|
|
|
$
|
93,909
|
|
|
$
|
92,352
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
September 30,
|
|
September 30,
|
||||||||||||
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
|
|
(in thousands)
|
||||||||||||||
|
Warranty, beginning of period
|
$
|
260
|
|
|
$
|
32
|
|
|
$
|
139
|
|
|
$
|
165
|
|
|
Warranty costs accrued
|
—
|
|
|
136
|
|
|
354
|
|
|
320
|
|
||||
|
Settlements of warranty claims
|
(192
|
)
|
|
(151
|
)
|
|
(425
|
)
|
|
(468
|
)
|
||||
|
Warranty, end of period
|
$
|
68
|
|
|
$
|
17
|
|
|
$
|
68
|
|
|
$
|
17
|
|
|
•
|
The first gaming headsets for the PlayStation®4 and Xbox One with DTS Headphone:X 7.1 surround sound technology, an innovative new sound experience designed to make movies, music and games sound better over headphones.
|
|
•
|
The first gaming headset to provide fully wireless game and chat audio for the Xbox One.
|
|
•
|
The first headset for the PlayStation®4 with noise cancellation and invisible microphones.
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
|
September 30,
|
|
September 30,
|
||||||||||||
|
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
|
|
|
(in thousands)
|
||||||||||||||
|
Net loss
|
|
$
|
(5,638
|
)
|
|
$
|
(1,402
|
)
|
|
$
|
(17,846
|
)
|
|
$
|
(7,044
|
)
|
|
Interest expense
|
|
866
|
|
|
2,017
|
|
|
6,161
|
|
|
4,580
|
|
||||
|
Depreciation and amortization
|
|
1,602
|
|
|
1,412
|
|
|
5,147
|
|
|
3,763
|
|
||||
|
Stock-based compensation
|
|
1,519
|
|
|
656
|
|
|
3,916
|
|
|
1,919
|
|
||||
|
Income tax benefit
|
|
(2,883
|
)
|
|
(3,699
|
)
|
|
(9,550
|
)
|
|
(7,186
|
)
|
||||
|
Business transaction costs
|
|
—
|
|
|
1,607
|
|
|
3,744
|
|
|
2,287
|
|
||||
|
Payments to founders
|
|
—
|
|
|
—
|
|
|
—
|
|
|
527
|
|
||||
|
Adjusted EBITDA
|
|
$
|
(4,534
|
)
|
|
$
|
591
|
|
|
$
|
(8,428
|
)
|
|
$
|
(1,154
|
)
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
September 30,
|
|
September 30,
|
||||||||||||
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
|
|
(in thousands)
|
||||||||||||||
|
Net Revenue
|
$
|
33,325
|
|
|
$
|
38,299
|
|
|
$
|
93,909
|
|
|
$
|
92,352
|
|
|
Cost of Revenue
|
25,576
|
|
|
29,653
|
|
|
69,053
|
|
|
68,759
|
|
||||
|
Gross Profit
|
7,749
|
|
|
8,646
|
|
|
24,856
|
|
|
23,593
|
|
||||
|
Operating expenses
|
15,070
|
|
|
11,947
|
|
|
45,852
|
|
|
32,987
|
|
||||
|
Operating loss
|
(7,321
|
)
|
|
(3,301
|
)
|
|
(20,996
|
)
|
|
(9,394
|
)
|
||||
|
Interest expense
|
866
|
|
|
2,017
|
|
|
6,161
|
|
|
4,580
|
|
||||
|
Other non-operating expense (income), net
|
334
|
|
|
(217
|
)
|
|
239
|
|
|
256
|
|
||||
|
Loss before income tax benefit
|
(8,521
|
)
|
|
(5,101
|
)
|
|
(27,396
|
)
|
|
(14,230
|
)
|
||||
|
Income tax benefit
|
(2,883
|
)
|
|
(3,699
|
)
|
|
(9,550
|
)
|
|
(7,186
|
)
|
||||
|
Net loss
|
$
|
(5,638
|
)
|
|
$
|
(1,402
|
)
|
|
$
|
(17,846
|
)
|
|
$
|
(7,044
|
)
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
September 30,
|
|
September 30,
|
||||||||||||
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
|
|
(in thousands)
|
||||||||||||||
|
Selling and marketing
|
$
|
7,962
|
|
|
$
|
7,665
|
|
|
$
|
22,660
|
|
|
$
|
21,783
|
|
|
Research and development
|
2,797
|
|
|
1,027
|
|
|
6,866
|
|
|
3,239
|
|
||||
|
General and administrative
|
4,311
|
|
|
1,648
|
|
|
12,582
|
|
|
5,678
|
|
||||
|
Business transaction costs
|
—
|
|
|
1,607
|
|
|
3,744
|
|
|
2,287
|
|
||||
|
Total operating expenses
|
$
|
15,070
|
|
|
$
|
11,947
|
|
|
$
|
45,852
|
|
|
$
|
32,987
|
|
|
|
Nine Months Ended
|
||||||
|
|
September 30,
|
||||||
|
|
2014
|
|
2013
|
||||
|
|
(in thousands)
|
||||||
|
Cash and cash equivalents at beginning of period
|
$
|
6,509
|
|
|
$
|
5,219
|
|
|
Net cash provided by (used for) operating activities
|
(12,097
|
)
|
|
15,259
|
|
||
|
Net cash provided by (used for) investing activities
|
2,146
|
|
|
(4,109
|
)
|
||
|
Net cash provided by (used for) financing activities
|
7,886
|
|
|
(11,335
|
)
|
||
|
Effect of foreign exchange on cash
|
(28
|
)
|
|
28
|
|
||
|
Cash and cash equivalents at end of period
|
$
|
4,416
|
|
|
$
|
5,062
|
|
|
|
|
Payments Due by Period
|
||||||||||||||||||
|
|
|
(in thousands)
|
||||||||||||||||||
|
|
|
Total
|
|
Less Than One Year
|
|
1 - 3 Years
|
|
3 - 5 Years
|
|
More Than Five Years
|
||||||||||
|
Contractual Obligations: (1)
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Operating lease obligations (2)
|
|
$
|
3,124
|
|
|
$
|
812
|
|
|
$
|
1,161
|
|
|
$
|
1,105
|
|
|
46
|
|
|
|
Series B redeemable preferred stock (3)
|
|
51,928
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
51,928
|
|
|||||
|
Principal payments on long term debt (4)
|
|
28,663
|
|
|
28,663
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
Subordinated notes (5)
|
|
7,506
|
|
|
7,506
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
Total
|
|
$
|
91,221
|
|
|
$
|
36,981
|
|
|
$
|
1,161
|
|
|
$
|
1,105
|
|
|
$
|
51,974
|
|
|
•
|
our ability to timely demonstrate or manufacture reliable products that have the features required by our HyperSound customers;
|
|
•
|
our ability to develop relationships with new customers that will lead to sales of our HyperSound products or licensing of our HyperSound technology;
|
|
•
|
our ability to develop and expand into new markets for our HyperSound audio products and technology; and
|
|
•
|
our ability to develop international product distribution or licensing directly or through partners.
|
|
•
|
If our forecasts of demand for products are too high, we may accumulate excess inventories of products, which could lead to markdown allowances or write-offs affecting some or all of such excess inventories. We may also have to adjust the prices of our existing products to reduce such excess inventories.
|
|
•
|
If demand for specific products increases beyond what we forecast, our suppliers and third-party manufacturers may not be able to increase production rapidly enough to meet the demand. Our failure to meet market demand would lead to missed opportunities to increase our base of users, damage our relationships with retailers and harm our business.
|
|
•
|
The launch of next-generation consoles increases the likelihood that we could fail to accurately forecast demand for our next-generation console headsets and our existing headsets.
|
|
•
|
Rapid increases in production levels to meet unanticipated demand could result in increased manufacturing errors, as well as higher component, manufacturing and shipping costs, all of which could reduce our profit margins and harm our relationships with retailers and consumers.
|
|
•
|
trade restrictions, higher tariffs, currency fluctuations or the imposition of additional regulations relating to import or export of our products, especially in China, where all of our Turtle Beach products are manufactured, which could force us to seek alternate manufacturing sources or increase our expenses, either of which could have a material adverse effect on our results of operations;
|
|
•
|
difficulties obtaining domestic and foreign export, import and other governmental approvals, permits and licenses, and compliance with foreign laws, which could halt, interrupt or delay our operations if we cannot obtain such approvals, permits and licenses, and that could have a material adverse effect on our results of operations;
|
|
•
|
difficulties encountered by our international distributors or us in staffing and managing foreign operations or international sales, including higher labor costs, which could increase our expenses and decrease our net sales and profitability;
|
|
•
|
transportation delays and difficulties of managing international distribution channels, which could halt, interrupt or delay our operations;
|
|
•
|
longer payment cycles for, and greater difficulty collecting, accounts receivable, which could reduce our net sales and harm our financial results;
|
|
•
|
political and economic instability, including wars, terrorism, political unrest, boycotts, curtailment of trade and other business restrictions, any of which could materially and adversely affect our net sales and results of operations; and
|
|
•
|
natural disasters, which could have a material adverse effect on our results of operations.
|
|
•
|
cease selling, incorporating or using products or services that incorporate the challenged intellectual property;
|
|
•
|
obtain a license from the holder of the infringed intellectual property right, which license may not be available on reasonable terms, if at all; and
|
|
•
|
redesign products or services that incorporate the disputed technology.
|
|
10.2
|
Amendment No. 1 to the Stockholder Agreement, dated July 10, 2014, by and among the Company and the Extending Shareholders.
Incorporated by reference to Exhibit 10.2 to the Form 8-K of the Company filed on July 11, 2014.
|
|
|
|
|
31.1
|
Certification of Juergen Stark, Principal Executive Officer, pursuant to Rule 13a-14(a) or 15d-14(a) of the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
31.2
|
Certification of John T. Hanson, Principal Financial Officer, pursuant to Rule 13a-14(a) or 15d-14(a) of the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
32.1
|
Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by Juergen Stark, Principal Executive Officer and John Hanson, Principal Financial Officer.
|
|
|
|
|
|
Extensible Business Reporting Language (XBRL) Exhibits
|
|
101.INS
|
XBRL Instance Document
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
101.LAB
|
XBRL Taxonomy Extension Labels Linkbase Document
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
TURTLE BEACH CORPORATION
|
|
|
|
|
|
Date: November 10, 2014
|
By:
|
/S/ JOHN T. HANSON
|
|
|
|
John T. Hanson
Chief Financial Officer, Treasurer and Secretary
|
|
|
|
(Principal Financial Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|